WHO ICTRP trial
Dose finding study for effective reversal of a moderate rocuronium-induced…
EUCTR2009-016857-16-BE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2009-016857-16-BE |
|---|---|
| Public title | Dose finding study for effective reversal of a moderate rocuronium-induced neuromuscular block with sugammadex in morbidly obese patients |
| Scientific title | Dose finding study for effective reversal of a moderate rocuronium-induced neuromuscular block with sugammadex in morbidly obese patients |
| Primary sponsor | University Hospital Ghent |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Belgium |
| Conditions | Morbidly obese patients |
| Interventions | Trade Name: Bridion Product Name: Sugammadex Pharmaceutical Form: Solution for injection INN or Proposed INN: SUGAMMADEX CAS Number: 343306-71-8 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration… |
| Registration date | Apr 14, 2010 |
| Secondary IDs | AGO/2009/010 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: